ArticleEuropean journal of pediatrics2026
Lactate-albumin ratio as an early predictor of mortality in critically ill children: A prospective cohort study.
Article in European journal of pediatrics, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Early risk stratification in critically ill children relies on severity scores such as PRISM-III and PELOD-2, requiring multiple variables. The lactate-albumin ratio (LAR), a two-parameter marker, shows prognostic value in adult and paediatric critical illness. This study evaluated serial LAR for predicting PICU mortality and compared its performance at admission against PRISM-III and PELOD-2. This prospective cohort study enrolled 335 of 563 screened children aged 1 month to less than 13 years admitted to a tertiary-care PICU in South India over 12 months. Serum lactate and albumin were measured at 0, 12, 24, and 48 h. Discriminatory performance was assessed using ROC curve analysis with DeLong's test. Firth-penalized multivariable logistic regression identified independent predictors. Of 335 children, 42 (12.5%) were non-survivors. LAR at admission discriminated mortality with an area under the curve (AUC) of 0.859 (95% CI 0.806-0.907), exceeding PRISM-III (AUC 0.751) and PELOD-2 (AUC 0.759) at the same timepoint (p < 0.05 for both). LAR remained independently associated with mortality after adjustment for PRISM-III, sepsis, and vasoactive support (adjusted odds ratio 3.77, 95% CI 2.22-6.40, p < 0.001), and outperformed lactate and albumin. LAR remained persistently elevated in non-survivors through 48 h.Conclusions: LAR at admission discriminated PICU mortality better than PRISM-III and PELOD-2 and remained an independent predictor after adjustment. Serial LAR changes may be a useful adjunct in predicting prognosis, though their clinical utility requires further prospective study. Derived from two routine investigations, LAR may serve as a practical addition to severity scoring, pending external validation. What is Known • Mortality risk in critically ill children is estimated with multivariable severity scores such as PRISM-III and PELOD-2. • Lactate and albumin refl ect tissue perfusion and systemic infl ammation, and their ratio has been associated with mortality in critical illness. What is New • We hypothesised that the lactate-albumin ratio, from two routine blood tests, may predict PICU mortality at least as well as multivariable severity scores. • We also hypothesised that serial measurement over the fi rst 48 hours may add prognostic information beyond the admission value.
Indexed as
Identifiers
42881277What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.